bupropion has been researched along with desipramine in 52 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (17.31) | 18.7374 |
1990's | 8 (15.38) | 18.2507 |
2000's | 17 (32.69) | 29.6817 |
2010's | 18 (34.62) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Dalvie, D; Loi, CM; Smith, DA | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Becker, CA; Commissaris, RL; Ellis, DM; Fontana, DJ; Hill, TJ; Schefke, DM | 1 |
Del Medico, VJ; Dilsaver, SC; Jaeckle, S; Quadri, A | 1 |
Anisman, H; Shanks, N | 1 |
Bergman, J; Spealman, RD | 1 |
Cooper, TB; Perumal, AS; Smith, TM; Suckow, RF | 1 |
Altar, CA; Marshall, JF | 1 |
Cowdry, RW; Golden, RN; Markey, SP; Potter, WZ; Risby, ED; Rudorfer, MV | 1 |
Charney, DS; Heninger, GR; Price, LH | 1 |
Snyder, AM; Stricker, EM; Zigmond, MJ | 1 |
Clifford, DB; Hicks, FG; Rutherford, JL; Zorumski, CF | 1 |
Cloutier, G; Cubeddu, LX; Grippo, R; Gross, K; Harden, TK; Knowlton, G; Lerea, L; Shakarjian, M; Stat, M; Tanner, L | 1 |
Banov, M; Lafer, B; Rosenbaum, JF; Sachs, GS; Stoll, AL; Thibault, AB; Tohen, M | 1 |
Borowski, TB; Kirkby, RD; Kokkinidis, L | 1 |
Biederman, J; Spencer, T; Steingard, R; Wilens, T | 1 |
Lucki, I; Rénéric, JP | 1 |
Nelson, JC | 1 |
Petrie, EC; Szot, P; Veith, RC | 1 |
Gomita, Y; Nakagawa, T; Ohyama, T; Okamura, H; Ukai, K | 1 |
Bourin, M; Dailly, E; David, DJ; Hascoët, M; Ripoll, N | 1 |
Folk, JE; Isgor, C; Rice, KC; Torregrossa, MM; Watson, SJ; Woods, JH | 1 |
Andersen, MP; Hogg, S; Pouzet, B | 1 |
Biederman, J; Clark, S; Ditterline, JW; Hammerness, PG; Kwon, A; Moore, H; Morris, MC; Podolski, A; Scott, M; Spencer, TJ; Wilens, TE | 1 |
Banaschewski, T; Heise, CA; Himpel, S; Rothenberger, A | 1 |
Folk, JE; Rice, KC; Torregrossa, MM; Watson, SJ; Woods, JH | 1 |
Gerak, LR; Moerschbaecher, JM; Quinton, MS; Winsauer, PJ | 1 |
Aiso, S; Ito, M; Katada, M; Kawasaki, A; Matsuoka, M; Nishizawa, K; Terashita, K; Torii, K | 1 |
Rosenzweig-Lipson, S; Schechter, LE; Sukoff Rizzo, SJ | 1 |
Generaux, GT; McConn, DJ; Muir, KT; Reese, MJ; St John-Williams, L; Wurm, RM | 1 |
Bekkering, GE; Tuinier, S; Verbeeck, W | 1 |
Balci, F; Campbell, U; Hanania, T; Olivier, BE; Paterson, NE | 1 |
Hara, H; Hayashi, E; Kinoshita, M; Kuratani, K; Shimamura, M | 1 |
Cadeddu, R; Carboni, E; Ibba, M; Sadile, A | 1 |
Docherty, JR; Killian, LM | 1 |
Collins, SL; Contreras-Mora, HM; Correa, M; Errante, EL; Rowland, MA; Salamone, JD; Yohn, SE | 1 |
Buoli, M; Cahn, W; Serati, M | 1 |
Dudka, J; Poleszak, E; Serefko, A; Stasiuk, W; Świąder, K; Szopa, A; Wlaź, P; Wyska, E | 1 |
Domingues, K; Lino de Oliveira, C; Suman, PR; Theindl, LC; Zerbinatti, N | 1 |
5 review(s) available for bupropion and desipramine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Augmentation strategies with serotonergic-noradrenergic combinations.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bupropion; Clinical Trials as Topic; Depressive Disorder; Desipramine; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1998 |
The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.
Topics: Adrenergic alpha-Agonists; Adult; Antidepressive Agents, Tricyclic; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clonidine; Desipramine; Guanfacine; Humans; Imipramine; Nortriptyline; Propylamines | 2005 |
Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review.
Topics: Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Comorbidity; Desipramine; Evidence-Based Medicine; Humans; Lithium Carbonate; Monoamine Oxidase Inhibitors; Paroxetine; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2009 |
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Central Nervous System Stimulants; Desipramine; Dopamine Agents; Droxidopa; Drug Combinations; Duloxetine Hydrochloride; Guanfacine; Histamine Agents; Humans; Lisdexamfetamine Dimesylate; Lithium Compounds; Lobeline; Mecamylamine; Memantine; Modafinil; Morpholines; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Paroxetine; Pyridines; Pyridoxine; Pyrrolidonecarboxylic Acid; Quinazolinones; Reboxetine; Venlafaxine Hydrochloride; Wakefulness-Promoting Agents | 2016 |
5 trial(s) available for bupropion and desipramine
Article | Year |
---|---|
Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output.
Topics: Adult; Animals; Antidepressive Agents; Bupropion; Depressive Disorder; Desipramine; Female; Humans; Male; Melatonin; Mice; Middle Aged; Norepinephrine; Propiophenones; Tranylcypromine | 1988 |
Efficacy of lithium-tranylcypromine treatment in refractory depression.
Topics: Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Bupropion; Clinical Trials as Topic; Depressive Disorder; Desipramine; Double-Blind Method; Drug Therapy, Combination; Female; Hospitalization; Humans; Lithium; Male; Middle Aged; Propiophenones; Psychiatric Status Rating Scales; Serotonin; Tranylcypromine | 1985 |
Bupropion does not antagonize cardiovascular actions of clonidine in normal subjects and spontaneously hypertensive rats.
Topics: Adult; Animals; Blood Platelets; Blood Pressure; Bupropion; Clonidine; Desipramine; Heart Rate; Humans; Imipramine; In Vitro Techniques; Male; Propiophenones; Rats; Rats, Inbred Strains; Tritium; Yohimbine | 1984 |
A double-blind trial of bupropion versus desipramine for bipolar depression.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Bupropion; Desipramine; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lithium; Male; Pilot Projects; Prospective Studies | 1994 |
Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.
Topics: Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Bupropion; Central Nervous System Stimulants; Cross-Over Studies; Desipramine; Female; Heart Rate; Humans; Hypertension; Male; Methylphenidate; Middle Aged; Pemoline; Placebos; Practice Guidelines as Topic | 2005 |
42 other study(ies) available for bupropion and desipramine
Article | Year |
---|---|
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Chronic antidepressant and clonidine treatment effects on conflict behavior in the rat.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Clonidine; Conflict, Psychological; Desipramine; Female; Mianserin; Panic; Propiophenones; Rats; Rats, Inbred Strains; Time Factors; Trazodone | 1990 |
Pharmacological responsiveness of winter depression.
Topics: Adult; Antidepressive Agents; Bupropion; Depressive Disorder; Desipramine; Disorders of Excessive Somnolence; Female; Humans; Male; Middle Aged; Mood Disorders; Propiophenones; Psychiatric Status Rating Scales; Seasons; Tranylcypromine | 1990 |
Strain-specific effects of antidepressants on escape deficits induced by inescapable shock.
Topics: Amitriptyline; Animals; Antidepressive Agents; Bupropion; Desipramine; Electroshock; Escape Reaction; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Propiophenones; Reaction Time; Receptors, Serotonin; Species Specificity | 1989 |
Behavioral effects of histamine H1 antagonists: comparison with other drugs and modification by haloperidol.
Topics: Animals; Bupropion; Cocaine; Conditioning, Operant; Cyproheptadine; Desipramine; Diazepam; Dose-Response Relationship, Drug; Electroshock; Haloperidol; Histamine H1 Antagonists; Male; Propiophenones; Saimiri | 1988 |
Effect of plasma from patients containing bupropion and its metabolites on the uptake of norepinephrine.
Topics: Animals; Bupropion; Cerebral Cortex; Desipramine; Female; Humans; Norepinephrine; Propiophenones; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Striatal dopamine uptake and swim performance of the aged rat.
Topics: Aging; Animals; Bupropion; Corpus Striatum; Desipramine; Dopamine; Dopamine Antagonists; Male; Motor Activity; Nomifensine; Olfactory Bulb; Propiophenones; Rats; Rats, Inbred F344; Swimming | 1986 |
Stress-induced neurological impairments in an animal model of parkinsonism.
Topics: Animals; Bupropion; Corpus Striatum; Deoxyglucose; Desipramine; Dopamine; Dose-Response Relationship, Drug; Hydroxydopamines; Injections, Intraventricular; Male; Neural Pathways; Norepinephrine; Oxidopamine; Pargyline; Parkinson Disease, Secondary; Propiophenones; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stress, Physiological | 1985 |
Acute effects of antidepressants on hippocampal seizures.
Topics: Amitriptyline; Animals; Anticonvulsants; Antidepressive Agents; Bupropion; Desipramine; Epilepsy; Hippocampus; Imipramine; Maprotiline; Propiophenones; Rats; Trazodone | 1985 |
Amphetamine and antidepressant drug effects on GABA- and NMDA-related seizures.
Topics: Amphetamine; Animals; Antidepressive Agents; Bupropion; Desipramine; Male; Mice; N-Methylaspartate; Picrotoxin; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Seizures; Zimeldine | 1993 |
Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome.
Topics: Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clonidine; Desipramine; Female; Humans; Male; Nortriptyline; Tourette Syndrome; Treatment Outcome | 1993 |
Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Cyclopropanes; Desipramine; Duloxetine Hydrochloride; Fluoxetine; Male; Milnacipran; Motor Activity; Rats; Rats, Sprague-Dawley; Thiophenes | 1998 |
Bupropion and desipramine increase dopamine transporter mRNA expression in the ventral tegmental area/substantia nigra of rat brain.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Autoradiography; Brain Chemistry; Bupropion; Carrier Proteins; Desipramine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; In Situ Hybridization; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; RNA Probes; RNA, Messenger; Ventral Tegmental Area | 1998 |
Effect of dopaminergic drugs on the reserpine-induced lowering of hippocampal theta wave frequency in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Atropine; Bupropion; Cyclobutanes; Desipramine; Dopamine Agents; Dopamine Agonists; Hippocampus; Male; Methamphetamine; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine; Reserpine; Theta Rhythm | 2000 |
Antidepressant-like effects in various mice strains in the tail suspension test.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Bupropion; Citalopram; Depression; Desipramine; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Hindlimb Suspension; Imipramine; Male; Mice; Mice, Inbred Strains; Paroxetine; Selective Serotonin Reuptake Inhibitors; Species Specificity | 2003 |
The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Benzamides; Brain; Brain-Derived Neurotrophic Factor; Bupropion; Desipramine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Tolerance; Gene Expression Regulation; Immobilization; In Situ Hybridization; Male; Midazolam; Naltrexone; Narcotic Antagonists; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, trkB; Receptors, Opioid, delta; RNA, Messenger; Swimming; Time Factors; Up-Regulation | 2004 |
Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antipsychotic Agents; Bupropion; Citalopram; Desipramine; Dextroamphetamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Norepinephrine; Piperazines; Rats; Rats, Wistar; Reflex, Startle; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Thiazoles | 2005 |
Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Brain-Derived Neurotrophic Factor; Bupropion; Cerebral Cortex; Desipramine; Drug Tolerance; Fluoxetine; Hippocampus; Male; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; RNA, Messenger; Swimming; Time Factors | 2005 |
Effects of pregnanolone in rats discriminating cocaine.
Topics: Animals; Bupropion; Cocaine; Desipramine; Dextroamphetamine; Discrimination Learning; Dose-Response Relationship, Drug; Haloperidol; Male; Pregnanolone; Rats; Rats, Long-Evans; Receptors, GABA-A | 2006 |
Antidepressant-like effect of Cordyceps sinensis in the mouse tail suspension test.
Topics: 5-Hydroxytryptophan; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Bupropion; Chromatography, Supercritical Fluid; Clorgyline; Cordyceps; Desipramine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Fluoxetine; Head Movements; Hindlimb Suspension; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Motor Activity; Prazosin; Serotonin Antagonists; Sulpiride; Water | 2007 |
A novel approach for predicting antidepressant-induced sexual dysfunction in rats.
Topics: Animals; Antidepressive Agents; Bupropion; Desipramine; Disease Models, Animal; Dopamine Agonists; Fluoxetine; Long-Term Care; Male; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Sulfones; Vasodilator Agents; Yohimbine | 2008 |
An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Area Under Curve; Bupropion; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Desipramine; Drug Interactions; Enzyme Inhibitors; Humans; Microsomes, Liver | 2008 |
The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition.
Topics: Animals; Antidepressive Agents; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Desipramine; Diazepam; Dopamine Uptake Inhibitors; Fluvoxamine; Haloperidol; Imipramine; Male; Piperazines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology | 2011 |
Automated experimental system capturing three behavioral components during murine forced swim test.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Bupropion; Desipramine; Equipment Design; Fluvoxamine; Image Interpretation, Computer-Assisted; Imipramine; Male; Mice; Mice, Inbred Strains; Pattern Recognition, Automated; Psychomotor Performance; Swimming; Video Recording | 2011 |
Antidepressants share the ability to increase catecholamine output in the bed nucleus of stria terminalis: a possible role in antidepressant therapy?
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Citalopram; Desipramine; Dopamine; Dose-Response Relationship, Drug; Fluoxetine; Imipramine; Male; Morpholines; Norepinephrine; Rats, Sprague-Dawley; Reboxetine; Septal Nuclei; Time Factors | 2014 |
Cardiovascular stimulant actions of bupropion in comparison to cocaine in the rat.
Topics: Animals; Benzhydryl Compounds; Bupropion; Central Nervous System Stimulants; Cocaine; Desipramine; Electric Stimulation; Heart Ventricles; Hydroxamic Acids; In Vitro Techniques; Male; Modafinil; Myocardial Contraction; Nifedipine; Rats, Wistar; Vas Deferens | 2014 |
Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
Topics: Animals; Antidepressive Agents; Benzazepines; Bupropion; Choice Behavior; Desipramine; Dopamine Antagonists; Dose-Response Relationship, Drug; Fluoxetine; Haloperidol; Male; Motivation; Neurotransmitter Uptake Inhibitors; Piperazines; Rats, Sprague-Dawley; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2016 |
Influence of the selective antagonist of the NR2B subunit of the NMDA receptor, traxoprodil, on the antidepressant-like activity of desipramine, paroxetine, milnacipran, and bupropion in mice.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Brain; Bupropion; Chromatography, High Pressure Liquid; Cyclopropanes; Depressive Disorder; Desipramine; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Injections, Intraperitoneal; Male; Mice; Milnacipran; Motor Activity; Paroxetine; Piperidines; Receptors, N-Methyl-D-Aspartate | 2017 |
Failure to detect the action of antidepressants in the forced swim test in Swiss mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Butyric Acid; Desipramine; Fluoxetine; Immobility Response, Tonic; Male; Mice; Motor Activity | 2018 |